Aeterna Zentaris
AEZS
#10723
Rank
NZ$29.61 M
Marketcap
NZ$9.67
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.46. In 2022 the company made an earnings per share (EPS) of NZ-$7.91 a decrease over its 2021 EPS that were of NZ-$3.08.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$7.91157.14%
2021NZ-$3.08-41.48%
2020NZ-$5.26-64.46%
2019NZ-$14.80-240%
2018NZ$10.57-122.32%
2017NZ-$47.35-53.53%
2016NZ-$101.88-86.71%
2015NZ-$766.82-35.21%
2014NZ-$1,184-216.67%
2013NZ$1,015-123.3%
2012NZ-$4,354-40.8%
2011NZ-$7,355-6.45%
2010NZ-$7,863-27.91%
2009NZ-$10,906-61.61%
2008NZ-$28,40783.61%
2007NZ-$15,472-195.31%
2006NZ$16,233178.26%
2005NZ$5,834-330%
2004NZ-$2,536-80.05%
2003NZ-$12,71317.78%
2002NZ-$10,794515.93%
2001NZ-$1,753-68.6%
2000NZ-$5,582119.62%
1999NZ-$2,542-3.63%
1998NZ-$2,637

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.87-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$4.33-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.02-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.94-242.51%๐Ÿ‡บ๐Ÿ‡ธ USA